Early diagnosis and treatment of PAH improve survival

Robyn Kalda
Jan 19
1 min read

This study examined the causes of delayed diagnosis (diagnosis after approximately 22 months) of pulmonary arterial hypertension (PAH) and whether an earlier diagnosis (within six months) leads to better outcomes. They identified several factors associated with delayed diagnosis and found that earlier diagnosis and treatment were associated with better survival.

Read the Pulmonary Circulation article

Recent Posts

Blood test identified as a good biomarker for idiopathic PAH

A relatively simple, inexpensive, and minimally invasive test for idiopathic pulmonary arterial hypertension (IPAH) would aid in the diagnosis of this disease. This study found that levels of the NOTC

Doctors and patients recognize PAH symptom severity differently

As pulmonary arterial hypertension (PAH) patients became sicker, their self-reported quality of life was significantly worse than their doctors recognized. This discordance was associated both with wo

Racial and ethnic equity in PAH clinical trials

Looking at the racial and ethnic breakdown of patients with PAH and patients who take part in clinical trials, the authors conclude that the goal of equitable representation has not yet been reached.

Comments